Update on Important Drug Interactions, Side Effects Over the Past Year

Video

Doug Paauw, MD, attends the American College of Physicians Internal Medicine Meeting to provide an update on drug interactions and side effects prominent every year. At this year’s meeting (ACP 2017), Paauw went over some of those serious drug interactions with MD Magazine.

Doug Paauw, MD, professor of medicine at the University of Washington, attends the American College of Physicians Internal Medicine Meeting to provide an update on drug interactions and side effects prominent every year. At this year’s meeting (ACP 2017), Paauw went over some of those serious drug interactions with MD Magazine.

Paauw explained that the most common medication error involves insulin, however, he did not mention it in his talk at ACP because it is so widely understood.

“As far as medications, I focused a bit on quinolones because this group has come under great scrutiny by the FDA in this past year,” Paauw said. “Labeling changes have occurred to remove it as a regular and approved treatment for cystitis for acute sinusitis and for acute exacerbations on chronic bronchitis.”

Paauw went on to mention other drug interactions and side effects that made headlines during the past year. Watch the video above to find out the details.

>>> More Coverage from ACP 2017

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.